Copyright Reports & Markets. All rights reserved.

Global Tumor Targeted Drug Detection Kit Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Tumor Targeted Drug Detection Kit Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Single Gene Testing
    • 1.3.3 Multigene Testing
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Tumor Targeted Drug Detection Kit Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Online Sales
    • 1.4.3 Offline Sales
  • 1.5 Global Tumor Targeted Drug Detection Kit Market Size & Forecast
    • 1.5.1 Global Tumor Targeted Drug Detection Kit Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Tumor Targeted Drug Detection Kit Sales Quantity (2021-2032)
    • 1.5.3 Global Tumor Targeted Drug Detection Kit Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 BGI
    • 2.1.1 BGI Details
    • 2.1.2 BGI Major Business
    • 2.1.3 BGI Tumor Targeted Drug Detection Kit Product and Services
    • 2.1.4 BGI Tumor Targeted Drug Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 BGI Recent Developments/Updates
  • 2.2 Quest Diagnostics
    • 2.2.1 Quest Diagnostics Details
    • 2.2.2 Quest Diagnostics Major Business
    • 2.2.3 Quest Diagnostics Tumor Targeted Drug Detection Kit Product and Services
    • 2.2.4 Quest Diagnostics Tumor Targeted Drug Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Quest Diagnostics Recent Developments/Updates
  • 2.3 Gene By Gene（myDNA Inc.）
    • 2.3.1 Gene By Gene（myDNA Inc.） Details
    • 2.3.2 Gene By Gene（myDNA Inc.） Major Business
    • 2.3.3 Gene By Gene（myDNA Inc.） Tumor Targeted Drug Detection Kit Product and Services
    • 2.3.4 Gene By Gene（myDNA Inc.） Tumor Targeted Drug Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Gene By Gene（myDNA Inc.） Recent Developments/Updates
  • 2.4 DNA Diagnostics Center
    • 2.4.1 DNA Diagnostics Center Details
    • 2.4.2 DNA Diagnostics Center Major Business
    • 2.4.3 DNA Diagnostics Center Tumor Targeted Drug Detection Kit Product and Services
    • 2.4.4 DNA Diagnostics Center Tumor Targeted Drug Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 DNA Diagnostics Center Recent Developments/Updates
  • 2.5 Invitae
    • 2.5.1 Invitae Details
    • 2.5.2 Invitae Major Business
    • 2.5.3 Invitae Tumor Targeted Drug Detection Kit Product and Services
    • 2.5.4 Invitae Tumor Targeted Drug Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Invitae Recent Developments/Updates
  • 2.6 Ambry Genetics
    • 2.6.1 Ambry Genetics Details
    • 2.6.2 Ambry Genetics Major Business
    • 2.6.3 Ambry Genetics Tumor Targeted Drug Detection Kit Product and Services
    • 2.6.4 Ambry Genetics Tumor Targeted Drug Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Ambry Genetics Recent Developments/Updates
  • 2.7 Living DNA
    • 2.7.1 Living DNA Details
    • 2.7.2 Living DNA Major Business
    • 2.7.3 Living DNA Tumor Targeted Drug Detection Kit Product and Services
    • 2.7.4 Living DNA Tumor Targeted Drug Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Living DNA Recent Developments/Updates
  • 2.8 EasyDNA
    • 2.8.1 EasyDNA Details
    • 2.8.2 EasyDNA Major Business
    • 2.8.3 EasyDNA Tumor Targeted Drug Detection Kit Product and Services
    • 2.8.4 EasyDNA Tumor Targeted Drug Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 EasyDNA Recent Developments/Updates
  • 2.9 Pathway Genomics
    • 2.9.1 Pathway Genomics Details
    • 2.9.2 Pathway Genomics Major Business
    • 2.9.3 Pathway Genomics Tumor Targeted Drug Detection Kit Product and Services
    • 2.9.4 Pathway Genomics Tumor Targeted Drug Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Pathway Genomics Recent Developments/Updates
  • 2.10 Centrillion Technology
    • 2.10.1 Centrillion Technology Details
    • 2.10.2 Centrillion Technology Major Business
    • 2.10.3 Centrillion Technology Tumor Targeted Drug Detection Kit Product and Services
    • 2.10.4 Centrillion Technology Tumor Targeted Drug Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Centrillion Technology Recent Developments/Updates
  • 2.11 Color Genomics
    • 2.11.1 Color Genomics Details
    • 2.11.2 Color Genomics Major Business
    • 2.11.3 Color Genomics Tumor Targeted Drug Detection Kit Product and Services
    • 2.11.4 Color Genomics Tumor Targeted Drug Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Color Genomics Recent Developments/Updates
  • 2.12 Anglia DNA Services
    • 2.12.1 Anglia DNA Services Details
    • 2.12.2 Anglia DNA Services Major Business
    • 2.12.3 Anglia DNA Services Tumor Targeted Drug Detection Kit Product and Services
    • 2.12.4 Anglia DNA Services Tumor Targeted Drug Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Anglia DNA Services Recent Developments/Updates
  • 2.13 African Ancestry
    • 2.13.1 African Ancestry Details
    • 2.13.2 African Ancestry Major Business
    • 2.13.3 African Ancestry Tumor Targeted Drug Detection Kit Product and Services
    • 2.13.4 African Ancestry Tumor Targeted Drug Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 African Ancestry Recent Developments/Updates
  • 2.14 Canadian DNA Services
    • 2.14.1 Canadian DNA Services Details
    • 2.14.2 Canadian DNA Services Major Business
    • 2.14.3 Canadian DNA Services Tumor Targeted Drug Detection Kit Product and Services
    • 2.14.4 Canadian DNA Services Tumor Targeted Drug Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Canadian DNA Services Recent Developments/Updates
  • 2.15 DNA Family Check
    • 2.15.1 DNA Family Check Details
    • 2.15.2 DNA Family Check Major Business
    • 2.15.3 DNA Family Check Tumor Targeted Drug Detection Kit Product and Services
    • 2.15.4 DNA Family Check Tumor Targeted Drug Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 DNA Family Check Recent Developments/Updates
  • 2.16 Alpha Biolaboratories
    • 2.16.1 Alpha Biolaboratories Details
    • 2.16.2 Alpha Biolaboratories Major Business
    • 2.16.3 Alpha Biolaboratories Tumor Targeted Drug Detection Kit Product and Services
    • 2.16.4 Alpha Biolaboratories Tumor Targeted Drug Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Alpha Biolaboratories Recent Developments/Updates
  • 2.17 Test Me DNA
    • 2.17.1 Test Me DNA Details
    • 2.17.2 Test Me DNA Major Business
    • 2.17.3 Test Me DNA Tumor Targeted Drug Detection Kit Product and Services
    • 2.17.4 Test Me DNA Tumor Targeted Drug Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Test Me DNA Recent Developments/Updates
  • 2.18 23 Mofang
    • 2.18.1 23 Mofang Details
    • 2.18.2 23 Mofang Major Business
    • 2.18.3 23 Mofang Tumor Targeted Drug Detection Kit Product and Services
    • 2.18.4 23 Mofang Tumor Targeted Drug Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 23 Mofang Recent Developments/Updates
  • 2.19 Genetic Health
    • 2.19.1 Genetic Health Details
    • 2.19.2 Genetic Health Major Business
    • 2.19.3 Genetic Health Tumor Targeted Drug Detection Kit Product and Services
    • 2.19.4 Genetic Health Tumor Targeted Drug Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.19.5 Genetic Health Recent Developments/Updates

3 Competitive Environment: Tumor Targeted Drug Detection Kit by Manufacturer

  • 3.1 Global Tumor Targeted Drug Detection Kit Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Tumor Targeted Drug Detection Kit Revenue by Manufacturer (2021-2026)
  • 3.3 Global Tumor Targeted Drug Detection Kit Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Tumor Targeted Drug Detection Kit by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Tumor Targeted Drug Detection Kit Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Tumor Targeted Drug Detection Kit Manufacturer Market Share in 2025
  • 3.5 Tumor Targeted Drug Detection Kit Market: Overall Company Footprint Analysis
    • 3.5.1 Tumor Targeted Drug Detection Kit Market: Region Footprint
    • 3.5.2 Tumor Targeted Drug Detection Kit Market: Company Product Type Footprint
    • 3.5.3 Tumor Targeted Drug Detection Kit Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Tumor Targeted Drug Detection Kit Market Size by Region
    • 4.1.1 Global Tumor Targeted Drug Detection Kit Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Tumor Targeted Drug Detection Kit Consumption Value by Region (2021-2032)
    • 4.1.3 Global Tumor Targeted Drug Detection Kit Average Price by Region (2021-2032)
  • 4.2 North America Tumor Targeted Drug Detection Kit Consumption Value (2021-2032)
  • 4.3 Europe Tumor Targeted Drug Detection Kit Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Tumor Targeted Drug Detection Kit Consumption Value (2021-2032)
  • 4.5 South America Tumor Targeted Drug Detection Kit Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Tumor Targeted Drug Detection Kit Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Tumor Targeted Drug Detection Kit Sales Quantity by Type (2021-2032)
  • 5.2 Global Tumor Targeted Drug Detection Kit Consumption Value by Type (2021-2032)
  • 5.3 Global Tumor Targeted Drug Detection Kit Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Tumor Targeted Drug Detection Kit Sales Quantity by Application (2021-2032)
  • 6.2 Global Tumor Targeted Drug Detection Kit Consumption Value by Application (2021-2032)
  • 6.3 Global Tumor Targeted Drug Detection Kit Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Tumor Targeted Drug Detection Kit Sales Quantity by Type (2021-2032)
  • 7.2 North America Tumor Targeted Drug Detection Kit Sales Quantity by Application (2021-2032)
  • 7.3 North America Tumor Targeted Drug Detection Kit Market Size by Country
    • 7.3.1 North America Tumor Targeted Drug Detection Kit Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Tumor Targeted Drug Detection Kit Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Tumor Targeted Drug Detection Kit Sales Quantity by Type (2021-2032)
  • 8.2 Europe Tumor Targeted Drug Detection Kit Sales Quantity by Application (2021-2032)
  • 8.3 Europe Tumor Targeted Drug Detection Kit Market Size by Country
    • 8.3.1 Europe Tumor Targeted Drug Detection Kit Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Tumor Targeted Drug Detection Kit Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Tumor Targeted Drug Detection Kit Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Tumor Targeted Drug Detection Kit Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Tumor Targeted Drug Detection Kit Market Size by Region
    • 9.3.1 Asia-Pacific Tumor Targeted Drug Detection Kit Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Tumor Targeted Drug Detection Kit Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Tumor Targeted Drug Detection Kit Sales Quantity by Type (2021-2032)
  • 10.2 South America Tumor Targeted Drug Detection Kit Sales Quantity by Application (2021-2032)
  • 10.3 South America Tumor Targeted Drug Detection Kit Market Size by Country
    • 10.3.1 South America Tumor Targeted Drug Detection Kit Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Tumor Targeted Drug Detection Kit Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Tumor Targeted Drug Detection Kit Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Tumor Targeted Drug Detection Kit Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Tumor Targeted Drug Detection Kit Market Size by Country
    • 11.3.1 Middle East & Africa Tumor Targeted Drug Detection Kit Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Tumor Targeted Drug Detection Kit Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Tumor Targeted Drug Detection Kit Market Drivers
  • 12.2 Tumor Targeted Drug Detection Kit Market Restraints
  • 12.3 Tumor Targeted Drug Detection Kit Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Tumor Targeted Drug Detection Kit and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Tumor Targeted Drug Detection Kit
  • 13.3 Tumor Targeted Drug Detection Kit Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Tumor Targeted Drug Detection Kit Typical Distributors
  • 14.3 Tumor Targeted Drug Detection Kit Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Tumor Targeted Drug Detection Kit market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    This kit is an in vitro diagnostic reagent based on second-generation sequencing technology. Detection of common driver gene mutations in non-small cell lung cancer (EGFR, ALK, ROS1, BRAF, RET, ERBB2, NTRK, KRAS, etc.) and immunotherapy positive/negative/hyper-progression related genes. The types of mutations detected include point mutations, Insertions, deletions, rearrangements, fusions. The applicable sample type is paraffin-embedded tissue sample (FFPE).
    This report is a detailed and comprehensive analysis for global Tumor Targeted Drug Detection Kit market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Tumor Targeted Drug Detection Kit market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Tumor Targeted Drug Detection Kit market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Tumor Targeted Drug Detection Kit market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Tumor Targeted Drug Detection Kit market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Tumor Targeted Drug Detection Kit
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Tumor Targeted Drug Detection Kit market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BGI, Quest Diagnostics, Gene By Gene（myDNA Inc.）, DNA Diagnostics Center, Invitae, Ambry Genetics, Living DNA, EasyDNA, Pathway Genomics, Centrillion Technology, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Tumor Targeted Drug Detection Kit market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Single Gene Testing
    Multigene Testing
    Market segment by Application
    Online Sales
    Offline Sales
    Major players covered
    BGI
    Quest Diagnostics
    Gene By Gene（myDNA Inc.）
    DNA Diagnostics Center
    Invitae
    Ambry Genetics
    Living DNA
    EasyDNA
    Pathway Genomics
    Centrillion Technology
    Color Genomics
    Anglia DNA Services
    African Ancestry
    Canadian DNA Services
    DNA Family Check
    Alpha Biolaboratories
    Test Me DNA
    23 Mofang
    Genetic Health
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Tumor Targeted Drug Detection Kit product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Tumor Targeted Drug Detection Kit, with price, sales quantity, revenue, and global market share of Tumor Targeted Drug Detection Kit from 2021 to 2026.
    Chapter 3, the Tumor Targeted Drug Detection Kit competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Tumor Targeted Drug Detection Kit breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Tumor Targeted Drug Detection Kit market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Tumor Targeted Drug Detection Kit.
    Chapter 14 and 15, to describe Tumor Targeted Drug Detection Kit sales channel, distributors, customers, research findings and conclusion.

    Buy now